The nervous system can drive progressive lung fibrosis by molding the disease-linked activities of cells called fibroblasts, according to new work involving mouse models and patient samples. Targeting this nerve-fibroblast crosstalk mitigated the buildup of fibrotic tissue, suggesting that this axis could offer new leverage to treat this incurable condition. Lung fibrosis involves the buildup of fibrotic tissue in the organs, preventing lung cells from properly exchanging oxygen and carbon dioxide. This occurs due to the abnormal expansion of cells called fibroblasts, which produce connective and scar tissue. There are no treatments that can halt the core progression of lung fibrosis, and researchers still lack a full understanding of the mechanisms that skew fibroblasts toward a pro-fibrotic state. Now, Genta Ishikawa and colleagues show that signals from sympathetic nerves are a surprising driver of lung fibrosis – and could offer a way to mitigate the condition. They imaged mouse models of lung fibrosis and lung tissues taken from patients with one of two forms of the disease, finding that sympathetic nerve fibers appeared in fibrotic regions that contained high quantities of fibroblasts. Further work showed that these nerves triggered the production of fibrotic markers from fibroblasts through the neurotransmitter noradrenaline. However, inhibiting noradrenaline receptors in the fibroblasts slowed the buildup of connective tissue and mitigated fibrosis in the lungs of the rodents. "These findings establish a mode of nerve-fibroblast communication during tissue injury and fibrogenesis and provide proof-of-concept evidence for therapeutic interventions targeting this mechanism for clinical benefit," Ishikawa et al. conclude.
Scientists Identify Nerve-Fibroblast Crosstalk as Lung Fibrosis Target
American Association for the Advancement of Science (AAAS)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.